The Global OTC Pharmaceutical Market
2010-2025
Where will opportunities lie in this diverse market with growing demand worldwide?
In 2009, the global over-the-counter (OTC) pharmaceutical market generated revenues of more than $60bn. Our analyses show that total... |
Global Cardiovascular Drugs Market 2009-2024
Expanding Patent Populations and Disease Prevalence - Our New Pharma Report Highlights Sales Opportunities
Cardiovascular disorders are leading causes of death worldwide. Cardiovascular therapeutics form a central part of the global... |
Strategic Perspectives: Antidyslipidemics Current market is not conducive for growth
Introduction
The antidyslipidemic market is increasingly governed by cost concerns which appear to be more pressing than the safety and efficacy concerns. Cost-saving initiatives together with the continuing genericization are going... |
Drug Treatments for Leading Endocrine and Metabolic Diseases
The aim of this report is to provide a range of information - from detailed market analyses through industry trends - to quantify, qualify, and compare prescription products on the... |
Herbal Supplements, Prescription Drugs, Rx-to-OTC Products
A Comparison
The aim of this report is to provide a range of information-from detailed market analyses through industry trends-to quantify, qualify and compare the herbal supplement, prescription drug (including generics) and... |
Pharmacogenomics for Clinical Use and in Drug Development
Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat... |
World Market for Prescription Cardiovascular Drugs
2nd Edition
As one of the most competitive pharmaceutical markets, keeping track of the cardiovascular drug market can be a difficult undertaking. The range of therapeutic options available to physicians has expanded... |
Acute Coronary Syndrome
This report analyzes the global market for Acute Coronary Syndrome Therapeutics in US$ Million. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 60... |
Report on Lipid-Lowering Drugs Market
China's morbidity rate of hyperlipemia reaches above 7%, with 90 million patients, thus the lipid-lowering drugs market is a market of huge demand. This report analyzes the classification of hyperlipemia,... |
Lebanon Pharmaceuticals and Healthcare Report Q3
2011
BMI View: Lebanon spends an abnormally large proportion of its national income on pharmaceuticals and healthcare, which makes the country highly attractive to international drugmakers. BMI believes that health tourism... |
Dyslipidemia Therapeutics
This report analyzes the worldwide markets for Dyslipidemia Therapeutics in US$ Million by the following segments - Statins, and Non-Statins. The report provides separate comprehensive analytics for US, Japan, Europe,... |
Cardiovascular Therapeutic Drugs: Technologies and Global Markets
This study provides a comprehensive analysis of cardiovascular therapies on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease subsegments to... |
Pharmacogenomics: New Technologies
In the Development of Personalized Therapies
Pharmacogenomics and pharmacogenetics will have a major impact on the future of health care. Pharmacogenetics is the study of the genetic basis for individuals' variable drug responses, and is being... |
Biomarkers
The Expanding Global Market
Biomarker-based tests have been in existence for over a few decades now but their relevance to drug development and diagnostics applications in particular has gained momentum only recently. This is... |
Global Generics Guide: Part 2
Benchmarking country markets and strategic issue
Introduction
The generics market is undergoing significant change, with intense merger and acquisition activity, a raft of upcoming patent expiries and new legislation being enacted to promote generic prescription in the... |
Hypertension: Competing Treatments and Market Entry Considerations
Today, approximately 1 billion people worldwide have high
blood pressure, a figure expected to increase to 1.5 billion by 2025, affecting
1 in 3 adults over the age of 20 (Lancet. 2005;365:217-223).... |
Acute Coronary Syndrome (ACS) Drug Market Prospects
2011-2021
What are the commercial prospects for the pharmacological treatment of acute coronary syndrome? Our new report shows you its revenue potential from 2011 to 2021. We predict and explain the... |
Synthes GmbH Product Pipeline Analysis
Synthes GmbH Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights into a Scope's pipeline and investigational products. The report also provides details on clinical... |
Pharmaceuticals
The global outlook series on Pharmaceuticals provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report provides a bird's eye view of the pharmaceutical... |
Statins: The World Market
2011-2021
What will happen now in the statin drugs market?
What does the future hold for the statins industry and market? Our new report shows how the patent expiry of Lipitor and... |
Cardiovascular Drugs
This report analyzes the worldwide markets for Cardiovascular Drugs in US$ Million. Cardiovascular diseases can be prevented or treated using different classes of drugs. Broadly, the major classes of cardiovascular... |
